|
MYEF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.18980003416658E-09 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
3.32256444579571E-12 |
| Stage1-vs-Stage2 |
5.214000E-02 |
| Stage1-vs-Stage3 |
8.935900E-02 |
| Stage1-vs-Stage4 |
1.825250E-01 |
| Stage2-vs-Stage3 |
4.217400E-01 |
| Stage2-vs-Stage4 |
1.873660E-02 |
| Stage3-vs-Stage4 |
3.308200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.67280000027159E-07 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
5.588200E-01 |
| Caucasian-vs-Asian |
9.203400E-01 |
| AfricanAmerican-vs-Asian |
6.581200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.527800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
9.845300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.579600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.392820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.823430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.024800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.729200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.951000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.055200E-03 |
| Classical-VS-Follicular |
2.001200E-04 |
| Classical-VS-Other |
4.982400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.518800E-01 |
| Tall-VS-Other |
2.577800E-01 |
| Tall-VS-Normal |
4.44089209850063E-15 |
| Follicular-VS-Other |
8.352400E-02 |
| Follicular-VS-Normal |
5.19828624589991E-12 |
| Other-VS-Normal |
5.397000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.63846713974181E-12 |
| N0-vs-N1 |
6.587800E-04 |
|
|
